Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05508282 · ClinicalTrials.gov registry record · NA
Testing an App-Based Approach to Reading and Screen Time Guidance for Parents of Infants
A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT05508282: Completed NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT05508282 is a NA study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05508282, a NA study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
The American Academy of Pediatrics (AAP) recommends that parents read to their children as often as possible beginning in infancy and limits on screen time at all ages, yet many families question the value of reading to infants and are uncertain how to do so, and screen time is rising. This proposal is highly relevant to public health in that it involves a "how-to" approach to reading with infants and limiting screen time that is delivered during pediatric well-child visits within an established program (Reach Out and Read) using innovative materials: specially designed children's books and animated educational videos featured in a new mobile app (Reading Bees). It addresses important research gaps, compliments existing programs and empowers families, particularly from underserved backgrounds, to read more interactively and enjoyably with their babies, limit screen time, and improve early literacy skills, relationships and health outcomes.
Primary Outcome
Feasibility of Reading Bees app for reading and screen time guidance; includes time of presentation and barriers encountered
Interventions
- BEHAVIORAL Reading Bees app and children's book to enhance parent-infant reading quality (0-2 month visit)
- BEHAVIORAL Reading Bees app and children's book to encourage alternatives to digital media (6-month visit)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2022-06-30 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
What the finished NCT05508282 record still lists
NCT05508282 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Reading Bees app and children's book to enhance parent-infant reading quality (0-2 month visit) is the first listed.
NCT05508282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05508282 about?
NCT05508282 is a clinical study titled "Testing an App-Based Approach to Reading and Screen Time Guidance for Parents of Infants". The American Academy of Pediatrics (AAP) recommends that parents read to their children as often as possible beginning in infancy and limits on screen time at all ages, yet many families question the value of reading to infants and are uncertain how to do so, and screen time is rising. This proposal...
What is the current status of trial NCT05508282?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2022-06-30. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT05508282?
The interventions under investigation include: Reading Bees app and children's book to enhance parent-infant reading quality (0-2 month visit) (BEHAVIORAL), Reading Bees app and children's book to encourage alternatives to digital media (6-month visit) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05508282?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05508282's enrollment target sits among peer trials
160 628th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI